Arbutus Biopharma Corporation
Arbutus Biopharma Corporation（ABUS）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
abus · 股价预测 · 10 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 10 位华尔街分析师
Buy
10 位分析师
共识
评级分布
12 个月目标价
High
$8.50
Consensus
$8.50
+100.5% upside
Low
$8.50
Median: $8.5 · Last Close: $4.24
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $4.18 | ↓ 1.39% |
1-day model range: $4.16–$4.2. Peak: $4.2 (-1.39%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $6 | +32.1% |
| 2028 | $7 | +55.4% |
| 2029 | $7 | +70.5% |
| 2030 | $8 | +79.6% |
| 2031 | — | +84.9% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ABUS · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-11-14 | Chardan Capital | Maintains | Buy→Buy |
| 2025-08-11 | Chardan Capital | Maintains | Buy→Buy |
| 2025-03-28 | Chardan Capital | Maintains | Buy→Buy |
| 2025-01-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-20 | Chardan Capital | Maintains | Buy→Buy |
| 2024-11-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-07 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-06 | Chardan Capital | Maintains | Buy→Buy |
| 2024-09-05 | Jefferies | Maintains | Buy→Buy |
| 2024-08-02 | JMP Securities | Maintains | Market Outperform→Market Outperform |
Wall Street analysts have recently issued updated ratings on Arbutus Biopharma Corporation (ABUS) stock. Of the recent 67 rating actions, 11 were upgrades and 7 were downgrades. 10 analysts currently cover ABUS.
分析师推荐趋势
ABUS analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$14M
↑ 404.8% YoY
Revenue Next Year
$91M
↑ 568.4% YoY
EPS This Year
$-0.19
EPS Next Year
$0.29
↓ 257.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast ABUS EPS of $-0.19 for the current fiscal year, based on estimates from 1 analysts. The ABUS revenue forecast is $14M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
ABUS 股价预测由两类独立数据源支撑：来自 10 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ABUS 的共识目标价为 $8.50（+100.5% 上行空间），分析师共识为 Buy。
ABUS 的短期预测（明日）为 $4.18（-1.39%）。 ABUS 对 2027 年的股价预测均值为 $6。 ABUS 对 2030 年的预测区间为 $7–$8。
Arbutus Biopharma Corporation 在 NASDAQ 上市，代码 ABUS。ABUS 在 2027 年的整体展望偏积极，在覆盖分析师中约 80% 对应 Buy 共识。
常见问题
ABUS 预测 · 8 个问题根据 10 位华尔街分析师，ABUS 的 12 个月平均目标价为 $8.50，最高 $8.50、最低 $8.50。若有图表，中位目标价可在上方查看。相对当前价 $4.24，隐含约 +100.5% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.